What is the Future of DNA Methylation Inhibitors in Cancer Therapy?
The future of DNA methylation inhibitors in cancer therapy looks promising, with ongoing research focusing on optimizing their use and expanding their application to a broader range of cancers. Advances in precision medicine and biomarker identification may help tailor these treatments to individual patients, potentially improving their efficacy and minimizing side effects. Personalized approaches and combination therapies are likely to play a crucial role in the continued development and success of DNA methylation inhibitors in oncology.
